Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-06

FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved Hospira, Inc.'s supplemental application for diazepam (generic) under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)